Jeffrey Newcorn, MD
Enriched profileProfessor of Psychiatry and Pediatrics; Director, Division of ADHD and Learning Disorders · Icahn School of Medicine at Mount Sinai
Jeffrey Newcorn is Professor of Psychiatry and Pediatrics; Director, Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 458 publications with 31,480 citations (h-index 85); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Child & Adolescent Psychiatry profiles in the findmyKOL directory.
Data verified 14 Sept 2026
Overview
Updated 14 Oct 2026
Jeffrey Newcorn, MD, is Professor of Psychiatry and Pediatrics at Icahn School of Medicine at Mount Sinai. The public record shows 458 publications with 31,480 citations (h-index 85), centered on Attention Deficit Hyperactivity Disorder, Child and Adolescent Psychosocial and Emotional Development, Neural and Behavioral Psychology Studies. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 12 companies, 7 NIH-funded awards (2002–2026).
- Most recent indexed publication: 2025 · JMIR serious games
- Top research focus: Attention Deficit Hyperactivity Disorder
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 245.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Sponsor: Jeffrey Newcorn
- Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Sponsor: Icahn School of Medicine at Mount Sinai
Industry payments
Updated 14 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Supernus Pharmaceuticals, Inc.Program year20252 payments
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20254 payments
- Tris Pharma IncProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
89%Atypical Antipsychotic32.2%Quetiapine Fumarate66%Risperidone34%Part D<11 patientsCentral Nervous System Stimulant24.6%Dextroamphetamine-Amphet Er100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
11%Central alpha-2 Adrenergic Agonist11%Clonidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
7 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Randomized controlled trial comparing nonstimulant-first vs stimulant-first strategies in treating ADHD in adults
Upstate Medical University
FY2026$839,468R01MH146143 - Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Icahn School of Medicine at Mount Sinai
FY2020$211,875R21DA046029 - Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Icahn School of Medicine at Mount Sinai
FY2019$254,250R21DA046029
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- In utero exposure to ADHD medication and long-term offspring outcomes.
Molecular psychiatry
Article2023
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeffrey-newcorn-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jeffrey-newcorn-1093714
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/jeffrey-newcorn-9681a515b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Jeffrey-Newcorn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/APSARD/videos/a-special-message-from-apsard-president-dr-jeffrey-newcorn-associate-professordi/504466027200194
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/mountsinainyc/posts/jeffrey-newcorn-md-associate-professor-of-psychiatry-and-pediatrics-and-director/1523864030977843
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/drpaulomattos/p/CxTyyc_O-qs
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - Instagram
instagram.com/p/CgCUX1XLCDe
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn: Jeffrey Newcorn - Prof of Psychiatry and Pediatrics; Icahn School of Medicine at Mount Sinai
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
ResearchGate profile: Jeffrey Newcorn, Director Division of ADHD and Learning Disorders; Director Pediatric Psychopharmacology, Icahn School of Medicine at Mount Sinai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
- Board Certified
Psychiatry and Child & Adolescent Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Founding board member and Past President
American Professional Society of ADHD and Related Disorders (APSARD)
2018provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →apsard.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacap.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- Director
Pediatric Psychopharmacology, Mount Sinai Health System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org ↗
- "Assessing Adult ADHD: A Conversation With Jeffrey Newcorn, MD" - video/article interview
Psychiatric Times (syndicated via CHADD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatrictimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons